Table I.
Basic features of the 15 Gene Expression Omnibus datasets.
| Cancer type | Accession number | Number of samples (tumor/control) | P-value |
|---|---|---|---|
| Breast | GSE42568 | 104/17 | <0.0001 |
| Ovarian | GSE14407 | 12/12 | 0.0407 |
| Hepatocellular carcinoma | GSE14520 | 214/214 | <0.0001 |
| Colorectal | GSE32323 | 17/17 | 0.0008 |
| Renal clear cell carcinoma | GSE36895 | 23/23 | 0.4799 |
| Prostate | GSE6919 | 56/56 | 0.1584 |
| Lung | GSE30219 | 293/14 | <0.0001 |
| Esophageal carcinoma | GSE20347 | 17/17 | 0.0001 |
| Pancreatic | GSE28735 | 45/45 | 0.8424 |
| Melanoma | GSE3189 | 45/25 | <0.0001 |
| Nasopharyngeal carcinoma | GSE12452 | 31/10 | 0.0043 |
| Gastric | GSE13911 | 31/31 | <0.0001 |
| Acute lymphoblastic leukemia | GSE26713 | 117/7 | <0.0001 |
| Papillary thyroid carcinoma | GSE3467 | 9/9 | 0.5215 |
| Myeloma | GSE27838 | 16/16 | 0.3133 |
P-values were obtained through the Mann-Whitney U test for the comparison of TRIM28 expression between tumor and control.